Patents by Inventor Kenneth Duke James, JR.

Kenneth Duke James, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antifungal agents and uses thereof
    Patent number: 12344680
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: July 1, 2025
    Assignee: Napp Pharmaceutical Group Limited
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman, Navdeep Balkrishna Malkar, Balasingam Radhakrishnan
  • Dosing regimens for echinocandin class compounds
    Patent number: 11654196
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: May 23, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Dosing regimens for echinocandin class compounds
    Patent number: 10702573
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: July 7, 2020
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Dosing regimens for echinocandin class compounds
    Patent number: 10016479
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: July 10, 2018
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Antifungal agents and uses thereof
    Patent number: 9676821
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: June 13, 2017
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman, Navdeep Balkrishna Malkar, Balasingam Radhakrishnan
  • Dosing regimens for echinocandin class compounds
    Patent number: 9526835
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 27, 2016
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Pharmaceutical compositions and uses thereof
    Patent number: 9308263
    Abstract: The invention features pharmaceutical compositions including (i) a drug, and (ii) a PEG fatty acid ester or PPG fatty acid ester in an amount sufficient to increase the oral bioavailability of the drug.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: April 12, 2016
    Assignee: Seachaid Pharmaceuticals, Inc.
    Inventors: Balasingam Radhakrishnan, Anuradha Vaidya, Navdeep Balkrishna Malkar, Karen Polowy, Kenneth Duke James, Jr.
  • Antifungal agents and uses thereof
    Patent number: 9217014
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: December 22, 2015
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman, Navdeep Balkrishna Malkar, Balasingam Radhakrishnan
  • DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS
    Publication number: 20150087583
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 26, 2015
    Applicant: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, JR., Anuradha Vaidya, Karen Polowy
  • PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    Publication number: 20140329793
    Abstract: The invention features pharmaceutical compositions including (i) a drug, and (ii) a PEG fatty acid ester or PPG fatty acid ester in an amount sufficient to increase the oral bioavailability of the drug.
    Type: Application
    Filed: October 19, 2012
    Publication date: November 6, 2014
    Applicant: SEACHAID PHARMACEUTICALS, INC.
    Inventors: Balasingam Radhakrishnan, Anuradha Vaidya, Navdeep Balkrishna Malkar, Karen Polowy, Kenneth Duke James, JR.
  • VANCOMYCIN DERIVATIVES
    Publication number: 20140171357
    Abstract: The invention features vancomycin class compounds modified to be suitable for oral delivery or to possess increased antimicrobial potency, formulations for the oral administration of vancomycin class compounds, and synthetic methods for making vancomycin class compounds.
    Type: Application
    Filed: March 23, 2012
    Publication date: June 19, 2014
    Applicant: Seachaid Pharmaceuticals, Inc.
    Inventors: Balasingam Radhakrishnan, Ronald George Sherrill, Kenneth Duke James, JR.
  • Antifungal agents and uses thereof
    Patent number: 8722619
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: May 13, 2014
    Assignee: Seachaid Pharmaceuticals, Inc.
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman
  • ECHINOCANDIN DERIVATIVES
    Publication number: 20120190613
    Abstract: The invention features echinocandin class compounds that have been modified to (i) have activity against one or more fungal species or genera; (ii) have increased aqueous solubility; (iii) have an increased therapeutic index; (iv) be suitable for topical administration; and/or (v) be suitable for oral administration. The echinocandin class compounds of the invention include, for example, a PEG, alkyl-PEG, aryl-PEG, alkaryl-PEG, PEG-alkyl, PEG-aryl, or PEG-alkaryl substituent.
    Type: Application
    Filed: August 26, 2010
    Publication date: July 26, 2012
    Inventors: Kenneth Duke James, JR., Christopher Patrick Laudeman